PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
1996 | 4 | 108-115
Article title

Antisense oligonucleotides: from the bench to the patients

Content
Title variants
Languages of publication
EN
Abstracts
EN
We describe here tha current state of progress toward gene-directed antisense-based cancer therapy targeting BCR/ABL, oncogene, primarily from the viewpoint of initial proof-of-concepts studies in animal models of human leukemias and phase I clinical investigations.
Journal
Year
Issue
4
Pages
108-115
Physical description
References
Document Type
article
Publication order reference
T.Skorski, Kimmel Cancer Center, Thomas Jefferson University, BLSB630, 233 South 10th Street, Philadephia, PA 19107, USA
YADDA identifier
bwmeta1.element.element-from-psjc-1cfc1613-86da-3918-a586-428516de46a5
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.